Results 191 to 200 of about 79,961 (249)

GHSA and Ebola technical areas : Targets and expected outcomes : CDC GHSA/Ebola Grantee Meeting : Day 2, February 11, 2016

ghsa-and-ebola-technical-areas-targets-and-expected-outcomes.pdfGHSA and Ebola technical areas : Targets and expected outcomes / Ray L Ransom -- GHSA and Ebola technical areas : Workforce development : targets and expected outcomes / Bassam Jarrar ...

core  

Risk behaviour associated with contracting the Ebola virus at funerals: a study of Liberians attending the funerals of individuals deceased from Ebola. [PDF]

Front Public Health
Stephens MT, Tangmunkongvorakul A, Kosashunhanan N, Fallah M, Gilayeneh JSM, Kie T, Srithanaviboonchai K.   +6 more
europepmc   +1 more source

Acceptability of the Ebola vaccine in the sub-Saharan African population: A systematic review and meta-analysis. [PDF]

BMC Infect Dis
Matangi B, Matondo P, Kayembe B, Okolo A, Tawaba D, Kinuka A, Mangala D, Odio O, Mayasi N, Lukiana T, Mandina M, Pindi T, Longokolo M, Mbula M, Situakibanza H, Bepouka B.   +15 more
europepmc   +1 more source

Ebola disease outbreak caused by Bundibugyo virus in Africa: A defining moment for Africa’s health security and sovereignty

Journal of Public Health in Africa
Yap Boum II, Nebiyu Dereje, Kyeng Mercy, Mosoka Fallah, Merawi Aragaw, Landry Tsague, Raji Tajudeen, Shanelle Hall, Ngashi Ngongo, Jean Kaseya   +9 more
doaj   +1 more source

A systematic review of infectious disease outbreaks and violence against women and girls: changes in magnitude, mechanisms and lessons for the future. [PDF]

BMJ Glob Health
Stark L, Noble DJ, Meinhart M, Erhardt-Ohren B, Karmin S, Poulton C, Sarraf D, Bustreo F, Seff I.   +8 more
europepmc   +1 more source

Operational strategies among infectious disease clinical trial sites during pandemics: a scoping review. [PDF]

Trials
Trigg KL, Zhang A, Wu AW.
europepmc   +1 more source

Marburg and Sudan virus outbreaks: are we any closer to a pan-filovirus vaccine? [PDF]

Trop Dis Travel Med Vaccines
Akingbola A, Adegbesan A, Adewole O, Olalude O, Isaiah O, Bhadmus F, Chuku J.   +6 more
europepmc   +1 more source

Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective. [PDF]

Front Immunol
Chen Y, Zhang Y, Zhang Y, Bie C, Wang R, Zhao Y, Lu M.   +6 more
europepmc   +1 more source

[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access]. [PDF]

Med Trop Sante Int
Potet J, Adjaho I, Dierberg K, Sprecher A, Coulborn RM.   +4 more
europepmc   +1 more source

An account of health systems resilience to emergencies in Africa: a scoping review. [PDF]

Global Health
Ankomah M, Abekah-Nkrumah G, Okai GA, Yarney L, Baku AAA.   +4 more
europepmc   +1 more source